233 related articles for article (PubMed ID: 22526534)
1. Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice.
Tobey KM; Walentiny DM; Wiley JL; Carroll FI; Damaj MI; Azar MR; Koob GF; George O; Harris LS; Vann RE
Psychopharmacology (Berl); 2012 Sep; 223(2):159-68. PubMed ID: 22526534
[TBL] [Abstract][Full Text] [Related]
2. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs.
Abdrakhmanova GR; Damaj MI; Carroll FI; Martin BR
Mol Pharmacol; 2006 Jun; 69(6):1945-52. PubMed ID: 16505153
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
Freitas K; Carroll FI; Negus SS
Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic acetylcholine alpha4beta2 receptor regulates the motivational effect of intracranial self stimulation behavior in the runway method.
Sagara H; Kitamura Y; Yae T; Shibata K; Suemaru K; Sendo T; Araki H; Gomita Y
J Pharmacol Sci; 2008 Dec; 108(4):455-61. PubMed ID: 19057129
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.
Ondachi P; Castro A; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
J Med Chem; 2012 Jul; 55(14):6512-22. PubMed ID: 22742586
[TBL] [Abstract][Full Text] [Related]
6. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.
McGranahan TM; Patzlaff NE; Grady SR; Heinemann SF; Booker TK
J Neurosci; 2011 Jul; 31(30):10891-902. PubMed ID: 21795541
[TBL] [Abstract][Full Text] [Related]
7. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
[TBL] [Abstract][Full Text] [Related]
8. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Nicotine Intake and Reward Function in Rats With Intermittent Short Versus Long Access to Nicotine.
Geste JR; Levin B; Wilks I; Pompilus M; Zhang X; Esser KA; Febo M; O'Dell L; Bruijnzeel AW
Nicotine Tob Res; 2020 Feb; 22(2):213-223. PubMed ID: 30958557
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
Maurer JJ; Sandager-Nielsen K; Schmidt HD
Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
12. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
Mohler EG; Franklin SR; Rueter LE
Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
[TBL] [Abstract][Full Text] [Related]
13. β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement.
Husson M; Harrington L; Tochon L; Cho Y; Ibañez-Tallon I; Maskos U; David V
J Neurosci; 2020 Apr; 40(17):3465-3477. PubMed ID: 32184221
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.
Semenova S; Jin X; McClure-Begley TD; Tadman MP; Marks MJ; Markou A
Pharmacol Biochem Behav; 2018 Aug; 171():54-65. PubMed ID: 29908200
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
16. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
Ondachi PW; Castro AH; Bartkowiak JM; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
J Med Chem; 2014 Feb; 57(3):836-48. PubMed ID: 24428686
[TBL] [Abstract][Full Text] [Related]
20. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.
Rezvani AH; Slade S; Wells C; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ; Levin ED
Psychopharmacology (Berl); 2017 Sep; 234(17):2517-2523. PubMed ID: 28555315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
